Back
Chemomab Therapeutics Ltd. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
21
CMMB
Chemomab Therapeutics Ltd.
Last Price:
$1.90
Seasonality Move:
25.93%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CMMB is experiencing selling pressure, which indicates risk of future bearish movement.
Chemomab Therapeutics Ltd. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.07 | Sell |
| 20-day SMA: | 2.35 | Sell |
| 50-day SMA: | 2.69 | Sell |
| 200-day SMA: | 3.92 | Sell |
| 8-day EMA: | 2.07 | Sell |
| 20-day EMA: | 2.29 | Sell |
| 50-day EMA: | 2.6 | Sell |
| 200-day EMA: | 3.77 | Sell |
Chemomab Therapeutics Ltd. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 31.3 | Sell |
| Chaikin Money Flow: | -26512 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.14 - 2.66) | Sell |
| Bollinger Bands (100): | (2.45 - 3.47) | Sell |
Chemomab Therapeutics Ltd. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Chemomab Therapeutics Ltd. Stock
Is Chemomab Therapeutics Ltd. Stock a Buy?
-
Chemomab Therapeutics Ltd. share price is 1.94 while CMMB 8-day simple moving average is 2.07, which is a Sell signal.
-
The stock price of CMMB is 1.94 while Chemomab Therapeutics Ltd. 20-day SMA is 2.35, which makes it a Sell.
-
Chemomab Therapeutics Ltd. 50-day simple moving average is 2.69 while CMMB share price is 1.94, making it a Sell technically.
-
CMMB stock price is 1.94 and Chemomab Therapeutics Ltd. 200-day simple moving average is 3.92, creating a Sell signal.
CMMB Technical Analysis vs Fundamental Analysis
Sell
21
Chemomab Therapeutics Ltd. (CMMB)
is a Sell
Is Chemomab Therapeutics Ltd. a Buy or a Sell?
-
Chemomab Therapeutics Ltd. stock is rated a SellThe current Chemomab Therapeutics Ltd. [CMMB] share price is $1.94. The Score for CMMB is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
Chemomab Therapeutics Ltd. Stock Info
Market Cap:
11.9M
Price in USD:
1.94
Share Volume:
51.5K
Chemomab Therapeutics Ltd. 52-Week Range
52-Week High:
9.84
52-Week Low:
1.73
Sell
21
Chemomab Therapeutics Ltd. (CMMB)
is a Sell
Chemomab Therapeutics Ltd. Share Price Forecast
-
What is the Chemomab Therapeutics Ltd. stock price today?The Chemomab Therapeutics Ltd. stock price is 1.94 USD today.
-
Will CMMB stock go up or go down?Chemomab Therapeutics Ltd.> share price is forecast to RISE/FALL based on technical indicators
-
Is Chemomab Therapeutics Ltd. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Chemomab Therapeutics Ltd. is overvalued.
Is Chemomab Therapeutics Ltd. Stock a Buy?
-
Chemomab Therapeutics Ltd. share price is 1.94 while CMMB 8-day exponential moving average is 2.07, which is a Sell signal.
-
The stock price of CMMB is 1.94 while Chemomab Therapeutics Ltd. 20-day EMA is 2.29, which makes it a Sell.
-
Chemomab Therapeutics Ltd. 50-day exponential moving average is 2.60 while CMMB share price is 1.94, making it a Sell technically.
-
CMMB stock price is 1.94 and Chemomab Therapeutics Ltd. 200-day simple moving average is 3.77, creating a Sell signal.
Fundamental Analysis of Chemomab Therapeutics Ltd.
Is Chemomab Therapeutics Ltd. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and a decrease next year of $0.12 per share.
Technical Analysis of Chemomab Therapeutics Ltd.
Should I short Chemomab Therapeutics Ltd. stock?
-
CMMB Moving Average Covergence Divergence (MACD) indicator is -0.2, suggesting Chemomab Therapeutics Ltd. is a Sell
-
Chemomab Therapeutics Ltd. Relative Strength Index (RSI) is 31.3, which suggest Chemomab Therapeutics Ltd. is oversold
-
The Bollinger Bands (25) for Chemomab Therapeutics Ltd. is (2.14 - 2.66), which suggest Chemomab Therapeutics Ltd. is a Sell
-
The Bollinger Bands (100) for Chemomab Therapeutics Ltd. is (2.45 - 3.47), which suggest Chemomab Therapeutics Ltd. is a Sell
* Chemomab Therapeutics Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.